Profile data is unavailable for this security.
About the company
Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Company’s product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the knee’s surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.
- Revenue in SEK (TTM)12.10m
- Net income in SEK-84.60m
- Incorporated2008
- Employees26.00
- LocationEpisurf Medical ABKarlavagen 60STOCKHOLM 114 49SwedenSWE
- Phone+46 86120020
- Websitehttps://episurf.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio Vitos Pharma AB | 1.11m | -14.84m | 47.28m | 1.00 | -- | 1.33 | -- | 42.64 | -0.1498 | -0.1498 | 0.006 | 0.0905 | 0.0457 | 0.092 | 3.02 | 1,108,910.00 | -61.08 | -31.11 | -62.90 | -32.92 | 90.59 | -- | -1,338.03 | -1,026.76 | 5.84 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
| iZafe Group AB | 4.77m | -31.86m | 56.10m | 8.00 | -- | 2.73 | -- | 11.76 | -0.1332 | -0.1332 | 0.0202 | 0.0747 | 0.1111 | 2.67 | 3.41 | 681,285.70 | -74.23 | -52.17 | -85.90 | -69.40 | -167.81 | -198.20 | -668.02 | -487.50 | 0.6358 | -- | 0.1085 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |
| Dignitana AB | 86.49m | -25.27m | 67.66m | 29.00 | -- | 6.91 | -- | 0.7822 | -0.3268 | -0.3268 | 1.13 | 0.1215 | 1.74 | 2.76 | 15.19 | 3,203,482.00 | -50.91 | -42.21 | -122.38 | -68.91 | 69.56 | 66.09 | -29.22 | -57.29 | 0.5202 | -9.97 | 0.609 | -- | 17.90 | 20.59 | 22.52 | -- | -15.31 | -- |
| Kontigo Care AB | 29.65m | 1.75m | 74.99m | 10.00 | 33.72 | 1.55 | 14.14 | 2.53 | 0.0694 | 0.0694 | 1.11 | 1.51 | 0.6241 | -- | 8.03 | -- | 3.68 | -0.4214 | 5.03 | -0.6195 | 69.93 | 66.31 | 5.89 | -0.5205 | -- | 10.00 | 0.0569 | -- | 1.80 | 16.95 | -92.68 | -- | 44.94 | -- |
| Codelab Capital AS | -97.31bn | -97.31bn | 76.50m | 29.00 | -- | 0.4974 | -- | -- | -- | -- | -- | 0.4624 | -- | -- | -- | -- | -- | -6.63 | -- | -7.43 | -- | 83.80 | -- | -39.82 | -- | -- | 0.00 | -- | -69.66 | -3.83 | 119.43 | -- | -12.19 | -- |
| Iconovo AB | 6.10m | -39.03m | 76.89m | 29.00 | -- | 0.626 | -- | 12.61 | -3.01 | -3.01 | 0.4526 | 7.71 | 0.0434 | -- | 1.04 | 210,251.40 | -27.76 | -25.43 | -31.28 | -28.24 | 323.68 | 134.57 | -640.15 | -215.16 | -- | -- | 0.0669 | -- | -58.65 | -9.88 | 4.71 | -- | 34.70 | -- |
| Ortivus AB | 75.12m | -24.17m | 77.39m | 38.00 | -- | 10.56 | -- | 1.03 | -0.5455 | -0.5455 | 1.70 | 0.1601 | 1.08 | 4.41 | 8.15 | 1,878,050.00 | -34.67 | -2.41 | -79.30 | -4.63 | 32.08 | 42.46 | -32.17 | -1.77 | 0.4501 | -54.17 | 0.7367 | -- | -19.55 | 10.00 | -409.66 | -- | 67.43 | -- |
| PMD Device Solutions AB | 51.91m | -43.42m | 80.23m | 37.00 | 0.5846 | -- | -- | 1.55 | 5.06 | 5.06 | 3.54 | -5.52 | 0.8624 | -- | 4.47 | -- | -72.13 | -- | -- | -- | 82.86 | -- | -83.64 | -- | 0.1121 | -1.88 | -- | -- | -- | -- | -- | -- | -- | -- |
| Episurf Medical AB | 12.10m | -84.60m | 82.68m | 26.00 | -- | 0.703 | -- | 6.83 | -0.2429 | -0.2429 | 0.0347 | 0.1807 | 0.0839 | -- | 6.21 | 432,142.80 | -58.81 | -47.46 | -67.73 | -52.01 | -- | -- | -700.83 | -1,019.29 | 6.11 | -- | 0.0321 | -- | 53.62 | 19.78 | -22.64 | -- | -0.4158 | -- |
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -40.41m | 83.13m | -- | -- | 1.61 | -- | -- | -0.2069 | -0.2069 | 0.00 | 0.1765 | 0.00 | -- | -- | -- | -35.38 | -25.12 | -45.41 | -28.54 | -- | -- | -- | -- | -- | -27.51 | 0.5953 | -- | -- | -- | -12.64 | -- | -- | -- |
| Clinical Laserthermia Systems AB | 15.20m | -68.04m | 89.60m | 7.00 | -- | 0.976 | -- | 5.90 | -10.14 | -10.14 | 2.19 | 5.32 | 0.287 | 11.20 | 4.24 | -- | -130.42 | -123.49 | -460.49 | -312.95 | -249.68 | -1,084.16 | -454.45 | -1,625.03 | 0.9119 | -18.95 | 0.0116 | -- | 31.99 | 35.55 | -12.92 | -- | 18.26 | -- |
| Toleranzia AB | 0.00 | -5.41m | 96.56m | 11.00 | -- | 0.639 | -- | -- | -0.026 | -0.026 | 0.00 | 0.7668 | 0.00 | -- | -- | 0.00 | -3.89 | -7.45 | -4.05 | -7.78 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Observe Medical ASA | -97.31bn | -97.31bn | 101.51m | 5.00 | -- | 0.6655 | -- | -- | -- | -- | -- | 0.5635 | -- | -- | -- | -- | -- | -32.60 | -- | -49.80 | -- | 32.83 | -- | -256.25 | 0.193 | -- | 0.3425 | -- | 43.14 | 204.81 | -18.82 | -- | 32.69 | -- |
| ScandiDos AB | 61.35m | -9.67m | 104.33m | 26.00 | -- | 2.39 | -- | 1.70 | -0.2068 | -0.2068 | 1.26 | 0.766 | 0.8184 | 1.31 | 6.88 | 1,978,871.00 | -12.90 | -12.60 | -23.54 | -21.76 | 50.39 | 51.58 | -15.76 | -15.37 | 0.9476 | -6.36 | 0.00 | -- | -1.82 | 4.36 | -60.62 | -- | -19.29 | -- |
| Luxbright AB | 4.20m | -22.23m | 107.05m | 10.00 | -- | 3.60 | -- | 25.47 | -0.24 | -0.24 | 0.0454 | 0.2641 | 0.104 | -- | 4.14 | 420,270.00 | -55.02 | -61.39 | -62.23 | -70.36 | -134.43 | -577.85 | -528.90 | -2,529.11 | 0.7743 | -4,539.47 | 0.0084 | -- | 55.58 | -- | -20.07 | -- | -- | -- |
| SciBase Holding AB (publ) | 25.71m | -59.24m | 109.77m | 27.00 | -- | 2.08 | -- | 4.27 | -0.4495 | -0.4495 | 0.1884 | 0.2409 | 0.299 | 0.7328 | 4.04 | 952,222.30 | -68.89 | -68.63 | -89.67 | -87.77 | 70.02 | 61.28 | -230.41 | -300.20 | 3.11 | -62.08 | 0.00 | -- | 29.93 | 27.50 | -28.75 | -- | 5.15 | -- |
Data as of Oct 08 2024. Currency figures normalised to Episurf Medical AB's reporting currency: Swedish Krona SEK
11.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rhenman & Partners Asset Management ABas of 30 Jun 2023 | 16.42m | 2.56% |
| Fj�rde AP-fondenas of 31 Dec 2022 | 16.25m | 2.53% |
| Tredje AP-fondenas of 31 Dec 2022 | 12.94m | 2.01% |
| Strand Kapitalf�rvaltning ABas of 31 Dec 2023 | 7.05m | 1.10% |
| Andra AP-fondenas of 31 Dec 2022 | 7.00m | 1.09% |
| Unionen (Investment Management)as of 31 Dec 2022 | 5.16m | 0.80% |
| Handelsbanken Fonder ABas of 31 Jul 2024 | 4.17m | 0.65% |
| Skandia Investment Management ABas of 31 May 2024 | 1.04m | 0.16% |
| Storebrand Asset Management ASas of 30 Jun 2024 | 968.50k | 0.15% |
| FCG Fonder ABas of 31 Dec 2023 | 883.85k | 0.14% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
